MODIFICATION
Q -- Blood Testing Services
- Notice Date
- 2/1/2006
- Notice Type
- Modification
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- Department of the Navy, Naval Supply Systems Command, FISC NORFOLK DETACHMENT PHILADELPHIA, 700 Robbins Avenue, Building 2B, Philadelphia, PA, 19111-5083
- ZIP Code
- 19111-5083
- Solicitation Number
- N00140-06-Q-0012
- Response Due
- 2/1/2006
- Archive Date
- 2/16/2006
- Description
- The Performance Work Statement and Schedule of Services contained in the combined synopsis/solicitation for RFQ N00140-06-Q-0012, which was previously posted on 1/27/06, is hereby amended as follows. A conformed version of the amended PWS in its entirety and Schedule of Services is provided below. The resultant contractor shall maintain and provide to Naval Hospital Great Lakes current and valid Government licenses, permits, and approvals as required under the FDA, CAP/CLIA and AABB to perform the required blood testing services (refer to sections 5 & 6, Licensure and Testing Compliance & Quality Assurance, Books and Records for further details). The resultant contractor shall pick up (at the contractor?s expense) prospective donor?s/patient?s blood, plasma or other blood component samples from Naval Hospital Great Lakes as requested throughout the week, exclusive of Federal Holidays, for testing at a mutually agreed upon time. Historically, samples have been picked up for testing at a minimum each Monday at 2000 hours with additional pick-up times provided throughout the course of the week as needs permit. The resultant contractor shall notify Naval Hospital, Laboratory Department, Great Lakes, Illinois of any damaged samples, inadequate documentation or other problems. The resultant contractor shall review and reconcile records and report initial test results by fax or other mutually agreed upon method by noon of the day following sample receipt to Naval Hospital Great Lakes (historically samples are picked up on Monday and initial test results faxed by noon on Tuesday). The contractor shall deliver a hard copy of the initial test results to Naval Hospital Great Lakes within 7 days following sample receipt. The contractor shall report the repeat results (performed in duplicate) on initially reactive samples to Naval Hospital Great Lakes by fax or other mutually agreed upon method within 24 hours after the initial reactive results have been received. The contractor shall report the results on confirmatory or supplemental test to Naval Hospital Great Lakes by certified letter or other mutually agreed upon method within 10 business days following receipt of repeat reactive results. In event that the contractor is unable to perform testing in a timely manner due to significant equipment, regent or regulatory causes, the contractor shall ship the Naval Hospital Great Lakes samples, at the contractor?s expense, to an acceptable laboratory site of Naval Hospital Great Lakes? choosing. The period of performance for the resultant purchase order will consist of a Base Period commencing 15 February 2006 through 30 September 2006, plus two additional one-year options as follows: Option 1: 01 October 2006 through 30 September 2007; and Option 2: 01 October 2007 through 30 September 2008. The Schedule of Services is as follows: Option 1: 01 October 2006 through 30 September 2007; and Option 2: 01 October 2007 through 30 September 2008. The quoter is required to price the following: BASE PERIOD: CLIN 0001 Donor Panel Testing Services; CLIN 0001AA Test samples of blood, plasma, or other blood components of prospective donor/patients in support of Naval Hospital Great Lakes, IL as per the Performance Work Statement requirements. The donor panel shall be comprised of the following test types: Antibody to HIV 1/HIV 2; Hepatitis B surface Antigen; Antibody to Hepatitis B Core Antigen; Antibody to HTLV 1/HTLV 2; A Serologic Test to Syphilis; Antibody to Hepatitis C Virus 2.0; ABO & Rh Typing; Antibody Screen for Clinically Significant Red Cell Antibodies; and Anti-Cytomegalovirus (CMV) EIA Screen. Donor Panel QTY 5,600 EACH; CLIN 0002 Confirmatory or Supplemental Testing for any positive component of the donor panel identified above in CLIN 0001. CLIN 0002 AA Hepatitis B Surface Antigen (Neut), QTY 110 each; CLIN 0002AB Anti-HCV RIBA 3.0, QTY 30 EACH; CLIN 0002AC Anti-HIV 1 Western Blot, QTY 20 EACH; CLIN 0002AD Anti-HTLV 1/HTLV 2 EIA, QTY 20 EACH; CLIN 0002AE Anti-HIV 2 EIA, QTY 20 EACH; CLIN 0002AF FTA-ABS, QTY 15 EACH; CLIN 0002AG HTLV 1 Immuno Blot, QTY 20 EACH; CLIN 0002AH Donor Antibody Identification, QTY 24 EACH. OPTION 1: CLIN 0003 Donor Panel Testing Services; CLIN 0003AA Test samples of blood, plasma, or other blood components of prospective donor/patients in support of Naval Hospital Great Lakes, IL as per the Performance Work Statement requirements. The donor panel shall be comprised of the following test types: Antibody to HIV 1/HIV 2; Hepatitis B surface Antigen; Antibody to Hepatitis B Core Antigen; Antibody to HTLV 1/HTLV 2; A Serologic Test to Syphilis; Antibody to Hepatitis C Virus 2.0; ABO & Rh Typing; Antibody Screen for Clinically Significant Red Cell Antibodies; and Anti-Cytomegalovirus (CMV) EIA Screen. Donor Panel QTY 8,500 EACH; CLIN 0004 Confirmatory or Supplemental Testing for any positive component of the donor panel identified above in CLIN 0003. CLIN 0004 AA Hepatitis B Surface Antigen (Neut), QTY 110 each; CLIN 0004AB Anti-HCV RIBA 3.0, QTY 30 EACH; CLIN 0004AC Anti-HIV 1 Western Blot, QTY 20 EACH; CLIN 0004AD Anti-HTLV 1/HTLV 2 EIA, QTY 20 EACH; CLIN 0004AE Anti-HIV 2 EIA, QTY 20 EACH; CLIN 0004AF FTA-ABS, QTY 15 EACH; CLIN 0004AG HTLV 1 Immuno Blot, QTY 20 EACH; CLIN 0004AH Donor Antibody Identification, QTY 24 EACH. OPTION 2: CLIN 0005 Donor Panel Testing Services; CLIN 0005AA Test samples of blood, plasma, or other blood components of prospective donor/patients in support of Naval Hospital Great Lakes, IL as per the Performance Work Statement requirements. The donor panel shall be comprised of the following test types: Antibody to HIV 1/HIV 2; Hepatitis B surface Antigen; Antibody to Hepatitis B Core Antigen; Antibody to HTLV 1/HTLV 2; A Serologic Test to Syphilis; Antibody to Hepatitis C Virus 2.0; ABO & Rh Typing; Antibody Screen for Clinically Significant Red Cell Antibodies; and Anti-Cytomegalovirus (CMV) EIA Screen. Donor Panel QTY 8,500 EACH; CLIN 0006 Confirmatory or Supplemental Testing for any positive component of the donor panel identified above in CLIN 0005. CLIN 0006 AA Hepatitis B Surface Antigen (Neut), QTY 110 each; CLIN 0006AB Anti-HCV RIBA 3.0, QTY 30 EACH; CLIN 0006AC Anti-HIV 1 Western Blot, QTY 20 EACH; CLIN 0006AD Anti-HTLV 1/HTLV 2 EIA, QTY 20 EACH; CLIN 0006AE Anti-HIV 2 EIA, QTY 20 EACH; CLIN 0006AF FTA-ABS, QTY 15 EACH; CLIN 0006AG HTLV 1 Immuno Blot, QTY 20 EACH; CLIN 0006AH Donor Antibody Identification, QTY 24 EACH. The time and date for the reciept of offers is hereby extended to 4:00pm (local time/Philadelphia, PA) on 06 February 2006.
- Record
- SN00978383-W 20060203/060201212536 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |